Two phase 3 clinical trials have shown that oral doses of a drug called BG-12 show "significant" and "clinically meaningful" reductions in multiple sclerosis (MS) relapses and brai...
The U.S. FDA this week approved a once-a-day pill for the treatment of multiple sclerosis (MS). The pill, being branded as "Aubagio" by Sanofi S.A., is specifically for the treatm...
Pfizer this week announced that Bosulif, a medication it developed for the treatment of a rare type of Leukemia, has been approved by the U.S. Food and Drug Administration.
The...
A study by the Group Health Research Institute in Seattle has determined that trastuzumab, the drug behind the brand name Herceptin, raises the risks for heart problems in breast c...
Gilead Sciences, a biotech research company, announced today that its new HIV treatment drug has been approved by the U.S. Food and Drug Administration. Dubbed Stribild, the once-...
GlaxoSmithKline (GSK) this week announced that phase III of trials for its new long-acting muscarinic antagonist/long-acting beta2 agonist (LAMA/LABA) drug are complete. The drug,...
Cocaine has always been that drug that I only hear about. I see people using it all the time in film, television and books, but I've never met a user in my life. I blame that on gr...
The Tour de France has been pretty clean for the last couple of years. Mostly since the whole doping thing got so out of hand that at one point the active yellow jersey holder and...
WebProNews is an iEntry Publication
